The present study describes phytoassisted synthesis of magnesium oxide nanoparticles with an aqueous extract of Swertia chirayaita. The stable magnesium oxide nanoparticles (MgONPs) formed by this method were spherical particles that were <20 nm in size. The method is cost-effective and eco-friendly. MgONPs from phytoassisted synthesis were characterized by UV-visible (UV-vis) spectroscopy, scanning electron microscopy (SEM), transmission electron microscopy (TEM), and X-ray diffraction (XRD). The UV-vis absorbance spectrum of the synthesized MgONPs displayed a surface plasmon resonance at 510 nm. XRD analysis showed that the MgONPs were crystalline in nature with a face-centred cubic geometry. 
Introduction
Current research in material science at the nano level has exposed diverse applications of nanoparticles compared to their macro-scaled counterparts. Nanoparticles have been shown to have utility in various fields of science. In biotechnological fields, metal-NPs have been found to be useful as catalysts, biosensors, conductors, diagnostic tools, and cytotoxic and antimicrobial agents. Notably, magnesium oxide is currently used to treat various ailments e.g., as an antacid for heartburn and sour stomach. It is a remarkably substantial material that is used in toxic-waste remediation [1] [2] [3] . Evidently, magnesium oxide has also been used as a catalyst [4, 5] and as an additive in refractories [6] , in superconducting products [7] and in paint [8] . A recent development in nano-science, nanoparticles of magnesium oxide have been used as adsorbents and catalysts [9, 10] . Notably, MgONPs have shown decent antibacterial properties against S. aureus and E. coli [11] and may be effective against various other harmful microbes. Widely, nanoparticles are prepared by various methods, and synthesis of nanoparticles through biological integrals is preferred over chemical and physical methods since the design process is simple, quick, cost-effective and eliminates the generation and use of hazardous substances. In the present study, Swertia chirayaita, belonging to the family Gentianaceae, is used as the reducing agent. It is an erect annual plant, native to the temperate Himalayas at altitudes of 1200-3000 m from Kashmir to Bhutan and at altitudes of 1200-1500 m in the Khasi hills in Meghalaya, India. Notably, S. chirayita is known for its medicinal importance in ancient medicine and is an abundant source of alkaloids and flavanoids, most of which are produced in abundance. Their roots have considerable antipyretic and analgesic effects and a number of therapeutic uses. S. chirayita has a large number of chemical constituents, including an estimated more than twenty polyhydroxylated xanthones, including swertinin, swerchirin, mangiferin, decussatin and isobellidifolin. A dimeric xanthone and a chiratanin have also been separated [12] . In Ayurveda, S. chirayita is used as an antipyretic, anthelmintic, antiperiodic, cathartic, and analeptic drug as well as a treatment for asthma, leucorrhoea, stomach ailments, inflammation, pregnant uteri, and never ending fevers [13, 14] . It is a remedy for ulcers, gastrointestinal diseases, skin diseases, cough, hiccups, liver and kidney diseases, neurological disorders and urogenital tract disorders. S. chirayita has also been used as purifier of breast milk and as a laxative and carminative [15, 16] . In recent studies, it has been found that MgONPs can be used to treat cancer [17] . Previously, silver and gold nanoparticles have been synthesized using green chemistry and have shown utility in drug delivery systems and antimicrobial effectiveness against Gramnegative and Gram-positive bacteria [18, 19] . Suresh et al. [20] explored the possibility of utilizing Nephelium lappaceum L. peel as a nontoxic, natural reducing agent for fabricating MgONPs, and the generated nanoparticles' size were in range of 60-70 nm. Previously, silver nanoparticles have been synthesized using plant materials and evaluated for antibacterial activity and were found to be impressive in their inhibitory activity against bacterial strains [21, 22] . Rajgovind et al. [23] studied using the heart wood of Pterocarpus marsupium for synthesizing metallic oxide nanoparticles and assessed their activity against Gram-positive bacteria and Gramnegative bacteria. The present study elaborates on the green chemistry concept to generate metal oxide nanoparticles using a medicinal plant material that acts as a reducing and capping agent. Experimentally, the whole plant of S. chirayaita was used for the development and design of nanoparticles. The synthesized MgONPs were characterized by a UV-vis spectrophotometer, scanning electron microscope (SEM), and transmission electron microscope (TEM), as well as via X-ray diffraction (XRD) analysis, and the nanoparticles were assessed for their prospective antibacterial application.
Materials and methods
Magnesium nitrate [Mg(NO 3 ) 2 ] used in this experiment was of the highest purity and obtained from Merck Mumbai, India.
Collection of plant
S. chirayaita was acquired from N.I.A. Madhovilas, Jaipur, India. Further, the plant species was identified and authenticated by a taxonomist/botanist from the Department of Botany, UOR, Jaipur India (Herbarium No. RUBL211522). Subsequently, the plant was washed, shade dried, subjected to fine grinding, and stored in air-tight container at 4 • C.
Synthesis of MgONPs
Ten grams of ultra-fine powder of whole plant material of S. chirayaita was boiled with 100 ml of distilled water at 80 • C for 20 min. The slurry was filtered through a pal funnel with Whatman filter paper No 1, and approximately 10 ml of the resulting filtrate was transferred into 30 ml of a 1 mM Mg(NO 3 ) 2 solution on a magnetic stirrer at 55 • C for 24 h. As a result, the solution developed a brownish colloidal appearance, indicating the formation of nanoparticles. Next, the solution was centrifuged at 15,000 rpm repeatedly with subsequent washings with distilled water, and the pallet was then calcined in a muffle furnace at 400 • C to obtain MgONPs. Subsequently, the pallet was ground and stored at 4 • C for further analysis.
Characterization of MgONPs
The formation of MgONPs by phytoassistance was monitored by measuring the UV-vis absorbance spectrum using a UV 1800 double-beam spectrophotometer (Shimadzu, Tokyo, Japan) operated from 200 to 800 nm. The corporal properties of the synthesized MgONPs were analyzed by transmission electron microscopy (TEM), scanning electron microscopy (SEM), and X-ray diffractometry (XRD). TEM analysis of the MgONPs was performed using a Techni G2, S-twin instrument operated at an accelerating voltage at 200 kV. The overhead structure and size distribution of the particles were observed using a Carl Zeiss EVO-18, 30 kV SEM machine. Phase identification of the MgONPs was performed using an Shimadzu XRD-6000 instrument at 30 kV and a 20 mA current with Cu Ka (I = 1.54Å).
Antibacterial activity study
(1 × 108 CFU/ml). Subsequently, 5-mm diameter agar wells were prepared by filling the wells with different volumes of the MgONPs solution or a standard drug solution. Further, all experimental plates were incubated at 37 • C for 24 h [24] . Eventually, the zones of inhibition were measured on the plates and the mean values were recorded. Notably, the assorted volumes of MgONPs used were 10 l, 20 l, 30 l and 40 l (0.25 g/l), and vancomycin was used as control. Tests were performed in triplicate [25] .
Results and discussion
In an exemplary response, the 10 ml of aqueous extract of S. chirayaita added to 30 ml of 1 mM Mg(NO 3 ) 2 solution with constant agitation at 55 • C for 24 h, changed from a green colour of the magnesium nitrate solution and S. chirayaita extract to dark brown. The colour change signalled the phyto-reduction of the magnesium nitrate by the aqueous extract of S. chirayaita and represented evidence of the successful biosynthesis of nanoparticles (Fig. 1) [26] .
UV-vis absorption spectra were recorded for MgONPs in the range of 200-800 nm using an aqueous MgONP suspension (Fig. 2) . The sample displayed an optical absorption peak at approximately 510 nm. The increasing shift of the UV-vis peak of MgONPs may be due to the aggregation of the nanoparticles as a metallic magnesium oxide nanoassemblage. The adynamic absorption peak at 200 nm is evidence of the existence of various organic compounds that interact with magnesium oxide ions in solution and implies a possible course for the reduction of the metal ions present in the solution. The morphology of the MgONPs was found to be spherical with minimal variations in size or shape, such as oval or elliptical particles. The edges of the particles were lighter than the centres, suggesting that the plant extract was capped with biomolecules. Analysis of the TEM micrography revealed that approximately 85% of the total particles observed had a size of approximately <20 nm. Scanning electron micrography showed that the MgONPs were spherical (Fig. 3) and the aggregation may be due to the interactions and Vander Waals forces between the MgONPs. These results agreed with those of an earlier study [27] .
The X-ray diffraction (XRD) patterns of the MgONPs are shown in Fig. 4, displaying (222), respectively, and no other peaks for impurities were detected. The average crystallite size, which was found to be <20 nm, was calculated from the diffraction peaks using the Debye-Scherrer equation [9] .
where d is the particle size of the crystal, k is the Sherrer constant (0.9), λ is the X-ray wavelength (0.15406 nm), β is the width of the XRD peak at half-height, and θ is the Bragg diffraction angle.
Antibacterial activity
The zones of inhibition that were measured to assess the antibacterial activities of MgONPs against Gram-negative (i.e., E. coli -MTCC-9721, P. vulgaris -MTCC-7299, K. pneumonia -MTCC-9751) and Grampositive (i.e., S. aureus -MTCC-9442, S. epidermidis -MTCC-2639, B. cereus -MTCC-9017) bacteria are shown in Table 1 and Fig. 5 . The MgONP suspension exhibited substantial antibacterial activity against Gramnegative and Gram-positive bacteria possibly because the MgONPs can easily enter the nucleus of the bacteria and provide an amazing surface area for interactions that hinders the growth mechanism [28, 29] . Furthermore, the metallic ions released from the surface of the NPs may be responsible for their antibacterial activity [30, 31] .
Other studies also revealed that the antibacterial activity of MgONPs and other nanoparticles relied on the presence of defects or oxygen vacancies at the surface of the nanoparticles, which led to lipid peroxidation and reactive oxygen species generation [32] [33] [34] [35] [37] concluded that the antibacterial effect of silver nanoparticles was more pronounced against Gram-negative than Gram-positive bacteria. The growth of all of the tested Gram-negative bacteria and Gram-positive bacteria was decreased at increasing concentrations of MgONPs, and the maximum inhibition of growth was obtained at a dose of 40 l.
Initial studies on the antimicrobial activities of metallic nanoparticles show that they have great promise for the food industry, for academics, for biomedical science and for many additional areas of science and technology as these materials may provide long lasting antibacterial activity due to their inherent properties of low volatility and high temperature stability [38] . The substantial increase in the magnitude and incidence of multiple drug resistant bacterial strains demands alternatives and consideration of metallic nanoparticles [39] . 
Conclusion
Phytoassisted synthesis of magnesium oxide nanoparticles with an aqueous extract of S. chirayaita is an eco-friendly and cost-effective method to synthesize magnesium oxide nanoparticles. The results of this study clearly show that the pathogenic strains tested are susceptible to MgONPs, which confirms their potential effectiveness against other bacterial strains. This result can be utilized to expand the use of these nanoparticles in biomedical fields.
